The landscape of neurological healthcare is undergoing a transformative period, with the global epilepsy drugs market standing at the forefront of this evolution. As medical science transitions from broad-spectrum treatments to precision, patient-centric therapies, the ability to manage and potentially control seizure disorders has reached unprecedented levels of efficacy. According to data...